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Introduction. There are numerous studies of stimulation of liver regeneration by 
transplantation of mesenchymal stem cells. Their effect is explained by direct intercellular 
interactions and paracrine communications. One of the alternative ways to influence on liver 
regeneration is injection of microvesicles. Microvesicles are extracellular vesicles that 
contain growth factors and cytokines and play a major role in intercellular paracrine 
communications. It is said, that in compare to cells microvesicles transplantation is not 
accompanied by risk of metaplasia and mutations, because they do not contain any genetic 
information.     
Aim. To study the effect of transplantation of mesenchymal stem cells microvesicles derived 
from adipose fat tissue on liver regeneration after partial hepatectomy in rats.  
Methods. Mesenchymal stem cells, isolated from visceral rat fatty tissue (adMSC), were 
treated by Cytochalasin B to derive microvesicles. These microvesicles were transplanted 
into portal vein of rats after partial hepatectomy. Control group of rats after partial 
hepatectomy received injection of PBS. On 2, 5, 7 and 14 days after operation rats were 
sacrificed. Functional parameters of liver were analyzed by biochemical tests, morphological 
changes were studied by immunohistochemical staining of liver slices with antibodies to 
desmin (HSC marker), Ki-67 (proliferation marker), α-SMA (myofibroblasts marker), CK-
19 (cholangiocytes marker).    
Results. According to immunohistochemistry results injection of microvesicles: 1) inhibits 
activation of HSC – there were 20% less desmin+ cells; 2) there were no transformation of 
HSC into α-SMA+ myofibroblasts and no risk of liver fibrosis; 3) inhibition of cellular 
proliferation. So, Ki-67+ hepatocytes number (area of portal tract and central vein) 
decreased in compare to control group. Number of Ki-67+ nonparenchymal cells in portal 
tract area was 2 times less, than in control. 4) there were no differences in CK-19 expression 
in experimental and control groups. As far as the cellular proliferation and thus liver 
regeneration was inhibited, we`ve seen higher numbers of ALT levels in experimental 
group. Decreased regeneration could be also visualized by lower triglycerides and 
cholesterol levels, there were less, than normal values. Blood urea nitrogen normalized in 
control group on 14
th
 day, but in experimental – on 7th day already.    
Conclusion. Injection of adMSC microvesicles inhibits general cellular response to partial 
hepatectomy. Inhibition of hepatocytes activation and proliferation slows down liver 
regeneration, that is proved by biochemical tests. Inhibition of HSC activation means also 
lesser risk of their transformation into myofibroblasts and fibrosis development. Thus 
microvesicles transplantation is not for stimulation of liver regeneration. Probably these 
inhibitory effects could be applied for treatment of liver fibrosis, that needs to be studied. 
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